NCT07088289

Brief Summary

The goal of this clinical trial is to explore whether a virtual reality (VR) mindfulness app is acceptable, appropriate, and feasible for supporting people with HIV and substance use problems. Participants will:

  • Use a VR headset with a mindfulness app at home;
  • Complete three online surveys over three months;
  • Take part in an individual interview or focus group to share their experiences.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable hiv

Timeline
13mo left

Started Feb 2026

Shorter than P25 for not_applicable hiv

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress20%
Feb 2026Jun 2027

First Submitted

Initial submission to the registry

July 19, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 28, 2025

Completed
6 months until next milestone

Study Start

First participant enrolled

February 1, 2026

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

July 28, 2025

Status Verified

July 1, 2025

Enrollment Period

1.2 years

First QC Date

July 19, 2025

Last Update Submit

July 19, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Intervention acceptability as measured by the Acceptability of Intervention Measure

    The Acceptability of Intervention Measure is a 4-item scale that assesses the extent to which participants find the intervention agreeable or satisfactory. Items are rated on a 5-point Likert scale ranging from 1 (Completely disagree) to 5 (Completely agree). Scores are averaged to create a total score, with higher scores indicating greater perceived acceptability of the intervention. Example items include: "I like \[intervention\]" and "\[intervention\] meets my approval."

    One-month follow-up

  • Intervention appropriateness as measured by the Intervention Appropriateness Measure

    The Intervention Appropriateness Measure is a 4-item scale designed to assess how suitable or relevant the intervention is for the target population. Each item is rated from 1 (Completely disagree) to 5 (Completely agree), and a total score is calculated by averaging responses. Higher scores reflect a stronger belief that the intervention is appropriate for the individual's needs or situation. Example items include: "\[intervention\] seems like a good match" and "\[intervention\] seems suitable."

    One-month follow up

  • Intervention feasibility as measured by the Feasibility of Intervention Measure

    The Feasibility of Intervention Measure includes 4 items that measure how practical and doable the intervention seems from the participant's perspective. Participants respond on a 5-point scale from 1 (Completely disagree) to 5 (Completely agree), with higher average scores indicating greater perceived feasibility. Example items include: "\[intervention\] seems implementable" and "\[intervention\] seems easy to use."

    One-month follow up

Secondary Outcomes (1)

  • Intervention engagement as measured by VR mindfulness app use frequency

    From enrollment to the end at 12 weeks.

Study Arms (1)

VR mindfulness

EXPERIMENTAL

Participants in this arm will receive a virtual reality (VR) mindfulness intervention named TRIPP. TRIPP is a commercially available VR mindfulness app designed to promote relaxation, focus, and emotional well-being through immersive, guided experiences. The app combines visual and auditory stimulation, breathwork, meditation, and interactive elements to help users reduce stress and improve mood.

Behavioral: TRIPP

Interventions

TRIPPBEHAVIORAL

In this study, participants will use TRIPP with a VR headset at home, engaging in short mindfulness sessions 3+ times per week for 4-12 weeks.

VR mindfulness

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Able to speak, read, and write in English
  • Aged 18 years or older
  • Diagnosed with HIV
  • Currently prescribed ART therapy
  • Reporting moderate to high risk related to alcohol, opioids, nicotine, cannabis, or stimulant use (score of 4 or higher on the Alcohol, Smoking, and Substance Involvement Screening Test - ASSIST). Participants may also use other substances, but the primary risk must fall within these categories, as these have the strongest research support for mindfulness-based interventions.
  • Having stable housing that allow using VR safely
  • Willing to provide contact information for at least one person whom the study team can reach if the participant becomes unreachable after repeated attempts

You may not qualify if:

  • Living in institutionalized settings or unsheltered
  • Terminal illness with a life expectancy of less than 6 months
  • Planning to move out of the area in the next eight weeks
  • Engaging in regular mindfulness practice outside of TRIPP
  • Experiencing fear of closed spaces or unable to tolerate wearing a VR headset (verified during orientation session)
  • Having visual or auditory impairments or severe physical disabilities that hinder VR use, history of seizures, severe cognitive impairment, severe motion sickness, severe unmanaged psychiatric symptoms, or currently pregnant
  • Participants without home internet access will not be excluded and will be provided either funding for internet service or VR headsets preloaded with TRIPP sessions for offline use.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Substance-Related Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Central Study Contacts

Audrey Hang Hai, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 19, 2025

First Posted

July 28, 2025

Study Start

February 1, 2026

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

June 1, 2027

Last Updated

July 28, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will share